Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, based on currently ...

The board of Vor Bio is exploring a potential sale, winding down operations and cutting the vast majority of its workforce.

The cell engineering company, co-founded by oncologist and writer Siddhartha Mukherjee, does not see a path forward for its ...

At the risk of stating the obvious, when evaluating a new EDC, step one is ensuring the EDC is in fact better. EDC technology ...

A new study finds cold plunges don’t help women recover from workouts, challenging the science behind a trend dominating ...

Hayley Jankowski has been interested in biomedical research since her freshman year of high school. Now, the Rowan University ...

As the cell and gene therapy (CGT) field continues to mature, many companies face a growing tension between scientific innovation and the realities of clinical development. Unsustainable costs, ...

US President Donald Trump’s ongoing efforts to reduce federal spending across government agencies have halted the development ...

Discover the diverse and interdisciplinary field of Translational and Molecular Medicine for a rewarding career in medical ...

A published thought leader and peer reviewer, Hiremath envisions a future where AI, smart implants, and digital health ...

As tassels turn, the Class of 2025 heads toward new jobs, new cities and new possibilities. Photo by Emily Paine, Marketing & ...